Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sunshine Biopharma's enterprise value was -$13.17M on Oct 19, 2026, against $70.33M a year earlier. Over the last 5 years it ranged from -$13.84M to $6.02B, with a median of $65.61M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | -$13.17M | -128.2% |
| 2025 | Dec 31, 2025 | $46.73M | -2.2% |
| 2024 | Dec 31, 2024 | $47.78M | -96.5% |
| 2023 | Dec 29, 2023 | $1.38B | -42.1% |
| 2022 | Dec 30, 2022 | $2.38B | -60.1% |
| 2021 | Dec 31, 2021 | $5.96B | +524.0% |
| 2020 | Dec 31, 2020 | $955.75M | – |